Page 5 - Daragh Oreilly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 
Ovoca Bio is a European-based biopharmaceutical company with a focus on women s health. The Company is currently developing a novel treatment for women with hypoactive sexual desire disorder (HSDD). 
 
The Company s lead product, BP-101, a novel synthetic peptide administered through a nasal spray, is clinically validated, with Phase II and Phase III studies conducted in Russia demonstrating statistically significant improvement in a number of key efficacy outcomes, including an increase in female sexual desire and reduction of symptoms of distress associated with HSDD.
 
Ovoca Bio is seeking to develop the drug for major global markets - in particular the United States and Europe, as well as obtain marketing approval in the Russian Federation. ....

United States , Russian Federation , Ovoca Bio , Daragh Oreilly , Chris Welsh , Carina Jurs , Chris Gardner , Kirill Golovanov , Consilium Strategic Communications , Annual General , Annual General Meeting , Chief Executive , Nominated Adviser , Euronext Growth Advisor , ஒன்றுபட்டது மாநிலங்களில் , ரஷ்ய கூட்டமைப்பு , கிறிஸ் வெல்ஶ் , கரினா ஜூர்ஸ் , கிறிஸ் கார்ட்னர் , கொன்சில்ிும் மூலோபாய தகவல்தொடர்புகள் , ஆண்டு ஜநரல் , ஆண்டு ஜநரல் சந்தித்தல் , தலைமை நிர்வாகி ,